Prostaglandin D2
- 1 lab in 1 country
- Funders: Korea Health Industry Development Institute and 3 more
- Cells1
Outcomes
5Progression to morula and blastocyst stages
upin cells1
1 study
Progression to morula and blastocyst stages
upin cells1
Prostaglandin D2 improves progression to morula and blastocyst stages in cells.
“PGD2 enhanced mitochondrial membrane potential, accelerated cleavage kinetics, and improved progression to the morula and blastocyst stages.”
Cellsembryo
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie23 May 2026
Estradiol and progesterone secretion
upin cells1
1 study
Estradiol and progesterone secretion
upin cells1
Prostaglandin D2 increases estradiol and progesterone secretion in cells.
“PGD2 promoted steroidogenic activation, evidenced by increased StAR and CYP11A1 expression and significantly elevated estradiol and progesterone secretion.”
Cellsovarian cells
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie23 May 2026
Mitochondrial membrane potential
upin cells1
1 study
Mitochondrial membrane potential
upin cells1
Prostaglandin D2 increases mitochondrial membrane potential in cells.
“Structural and functional analyses demonstrated restoration of mitochondrial network integrity, increased mitochondrial membrane potential (ΔΨm), elevated basal respiration, spare respiratory capacity, and ATP production”
Cellsovarian cells
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie23 May 2026
Senescence-associated beta-galactosidase
downin cells1
1 study
Senescence-associated beta-galactosidase
downin cells1
Prostaglandin D2 decreases senescence-associated beta-galactosidase in cells.
“PGD2 significantly enhanced cellular viability and attenuated senescence-associated β-galactosidase activity.”
Cellsovarian cells
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie23 May 2026
Cell viability
upin cells1
1 study
Cell viability
upin cells1
Prostaglandin D2 increases cell viability in cells.
“PGD2 significantly enhanced cellular viability and attenuated senescence-associated β-galactosidase activity.”
Cellsovarian cells
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie23 May 2026